Ravi Vinayak
Partner at Ventac Partners
San Francisco Bay Area
Overview
Work Experience
Managing Director
2023 - Current
At New Trail Consulting, I help life science, diagnostics, and research organizations expand globally through strategic distributor partnerships and tailored go-to-market plans. 🔹 What We Do: Identify, evaluate, and establish strong-performing distribution partners across EMEAI, APAC, LATAM, and Africa Build scalable channel strategies that accelerate sales of instruments and consumables Offer international advisory and board-level support for global business development Provide hands-on support in OEM, licensing, and revenue-growth strategies 💼 Representative Clients: DIALUNOX | Cambrian Bioworks | Paragon Genomics | Inventia Life Science | Provis Biolabs | List Biological Laboratories We bring deep technical understanding, global networks, and practical experience to help companies achieve measurable sales outcomes in competitive markets.
Partner
2023
Ventac Partners supports high-potential life science companies by providing strategic, financial, and operational expertise to drive innovation and growth. 🔹 Our Focus Areas: Fundraising support (equity capital raises, IPO/RTO readiness) Strategic partnering for in- and out-licensing opportunities M&A advisory and deal structuring for diagnostics and biopharma firms Innovation scouting and commercialization planning With an international presence in the US and Europe, we’ve built a successful portfolio of companies tackling transformative challenges in healthcare and diagnostics.
Ventac Partners work to advance healthcare and biotechnology innovations and create the maximum value for inventors and investors.
Vice President International Sales
2022 - 2023
At S2 Genomics, I led the global sales expansion for a breakthrough tissue sample preparation platform designed for NGS and single-cell biology. 🔹 Key Responsibilities: Built and managed a global network of channel partners across APAC, EMEAI, and LATAM Designed and executed international go-to-market strategies to penetrate emerging markets Supported distributor onboarding, training, and technical enablement Collaborated closely with R&D and product management to align market feedback with product development 🔹 Impact: Successfully launched the Singulator™ system into multiple international markets Increased global lead conversion through targeted partner enablement programs
S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications.
Raised $18,217,365.00 from BroadOak Capital Partners, Research Corporation Technologies and HealthTech Capital.
General Manager, Global Channel Distribution
2016 - 2022
Led the international distribution and OEM strategy for a leading provider of immunohistochemistry, immunofluorescence, glycobiology, and bioconjugation reagents. 🔹 Scope of Role: Managed relationships with 60+ global distributors and OEM partners Developed and executed sales enablement tools to drive international performance Oversaw strategic initiatives to grow revenue and improve market reach in academic, clinical, and industrial sectors 🔹 Key Achievements: Increased international channel revenue by streamlining partner engagement and performance tracking Launched co-branded and OEM products with global biotech and diagnostic companies
Vector Laboratories provides consumable reagents used in slide staining and imaging workflows within life science research.
Senior Director, Global Channel Sales
2016 - 2021
Oversaw global channel sales across all Maravai portfolio companies, with a focus on launching innovative life sciences tools and reagents into international markets. 🔹 Core Responsibilities: Built and managed strategic partnerships with key distributors across APAC, EMEA, and LATAM Worked with internal business units to commercialize advanced technologies such as mRNA production tools, viral vector QC, and oligo synthesis reagents Supported OEM deals and key accounts for product integration and licensing 🔹 Product Highlights: CleanCap®, GMPLink™ – Key technologies used in mRNA vaccine development AAE™, EndonucleaseGTP®, Protein A Mix-N-Go™ – Tools for bioproduction and QC Sterling™, Glen Pak™, Poly-Pak™ – Essential solutions for DNA/RNA synthesis workflows 🔹 Results: Drove consistent year-over-year growth through strategic expansion of international sales channels Successfully introduced multiple novel technologies to global life sciences and diagnostics markets
Maravai is a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines.
Raised $1,000,000,000.00 from GTCR.
Vice President, Sales and Business Development
2012 - 2016
BioMed Diagnostics' patented InTray™ and InPouch™ devices combine sample collection, transport, and culture in a single platform. No need to separately prepare a wet mount slide. Reduced risk of exposure or contamination. InTray™ products featuring Colorex™ technology enable easy-to-interpret visual results from a simple color change. As VP of worldwide business development and sales, I have set up Channel partnerships in India, South East Asia, South America and Europe. Focus is currently on generating new deals via OEM arrangements, increasing sales internationally and exploring growth in new but adjacent areas.
Biomed Diagnostics is highly selective prepoured media culture devices, designed to transport, isolate, and differentiate specimens.
Principal Managing Partner
2005 - 2016
Leading engagements focused on international channel partnerships, distribution channel management, business development, technology licensing and marketing, engaging directly with senior level decision makers. Clients include various small and mid-cap companies primarily in the life sciences, diagnostics and POC technologies. 1. Set up distribution channels for several US companies in emerging markets, some of which are: 2. Licensing and technology due diligence initiatives: 3. OEM engineering contracts for Global Biodiagnostics and Advanced Tear Diagnostics. - Advisor for companies developing disruptive technologies in the Point of Care disease diagnosis. 4. Founder of a start-up that focusses on commercialization of university technologies fostering global co-operation between academia and industry in life sciences and diagnostics. 5. Raise funds for a few Silicon Valley Biotech start-ups.
International Business Development Consultant
2013 - 2014
DiaCarta manufactures proprietary IVD tests for oncology and infectious diseases. We currently offer the QuantiVirus® HPV E6/E7 mRNA test for screening cervical and oral samples for the presence of high-risk HPV types ,which could cause cervical cancer and head-neck cancer. We also offer proprietary QClamp™ somatic mutation test kits such as EGFR, KRAS, NRAS, BRAF, PIK3CA, and. ALK.
Improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS
Raised $98,222,949.00 from Fortune Fountain Capital and Good Health Capital(GHC).
Channel Partnerships Consultant
2012 - 2014
Driving the sales in Asia for Class IV laser therapy in Pain Management; Set up distribution and sales channels in Asia. In order to accomplish this task I had to take special courses on Human and Veterinary Laser Therapy and became Certified Class 4 Laser Therapy technician. I treated patients suffering from a variety of bone and joint ailments.
LiteCure is a medical device company specializing in the use of Photobiomodulation for the reduction of pain and inflammation
Co-Founder
2012 - 2012
Rapator, Inc is an e-Commerce platform designed to provide access to thousands of life science products and services with a single click. The platform will provide cost effective marketing strategy for companies in emerging regions as well as companies in established markets and countries.